Press Release (ePRNews.com) - LONDON - Apr 15, 2016 - Narvitas Medical Devices International Limited, the London-based manufacturer of the proprietary and highly innovative LapDome® device, has teamed up with the Life Sciences Group at the UK Trade & Investment arm of the British Consulate based in New York to forge strategic relationships with US-based multi-national medical device companies specializing in laparoscopic surgery, to bring the LapDome laparoscopic surgery access device to the US market. In a parallel effort, the London-based UK Trade and Investment Group will team with Narvitas to expand the distribution of LapDome® further into the EU and Middle East.
LapDome® is a proprietary Narvitas technology which makes the initial access to the body in laparoscopic surgery safer and more rapid than the current standard of care.
“The commercialization of the CE marked LapDome® into the EU is well underway through our experienced sales consulting team,” said Glenn Foley, Chairman and CEO of Narvitas. “This collaborative relationship with the Life Sciences Group at the UK Trade & Investment Group will help accelerate that effort. Teaming up with them to leverage their relationships with the multi-national medical device companies sets us up to find the right market entry partner for the US market, the largest laparoscopic market in the world.”
About LapDome® Laparoscopic Access Device
LapDome® addresses a critical need in the laparoscopic surgical market (one of the largest medical procedure markets) and was developed to advance the standard of care for laparoscopic access. The LapDome device is a proprietary laparoscopic surgery access device. The device is a dome-shaped technology that utilizes negative pressure to raise the anterior abdominal wall for rapid and safe access to the abdominal cavity by surgical instruments.
www.narvitas.com Source :
Narvitas Medical Devices International Limited